NZ182810A - Solid stable choline salicylate compositions - Google Patents
Solid stable choline salicylate compositionsInfo
- Publication number
- NZ182810A NZ182810A NZ182810A NZ18281076A NZ182810A NZ 182810 A NZ182810 A NZ 182810A NZ 182810 A NZ182810 A NZ 182810A NZ 18281076 A NZ18281076 A NZ 18281076A NZ 182810 A NZ182810 A NZ 182810A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cholinesalicylate
- choline salicylate
- solid stable
- carboxy
- cellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65111076A | 1976-01-21 | 1976-01-21 | |
US05/705,056 US4067974A (en) | 1976-01-21 | 1976-07-14 | Stabilized solid form choline salicylate compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ182810A true NZ182810A (en) | 1979-12-11 |
Family
ID=27096002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ182810A NZ182810A (en) | 1976-01-21 | 1976-12-06 | Solid stable choline salicylate compositions |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS6051449B2 (es) |
AR (1) | AR217249A1 (es) |
AU (1) | AU511510B2 (es) |
CA (1) | CA1070299A (es) |
CH (1) | CH635816A5 (es) |
DD (1) | DD128908A5 (es) |
DE (2) | DE2760284C2 (es) |
DK (1) | DK149804C (es) |
EG (1) | EG12511A (es) |
ES (1) | ES454712A1 (es) |
FI (1) | FI56770C (es) |
FR (1) | FR2338705A1 (es) |
GB (2) | GB1575977A (es) |
GR (1) | GR62110B (es) |
HU (1) | HU175973B (es) |
IL (1) | IL50992A (es) |
MX (1) | MX5920E (es) |
NL (1) | NL183821C (es) |
NO (1) | NO145295C (es) |
NZ (1) | NZ182810A (es) |
RO (1) | RO71764A (es) |
SE (1) | SE418799B (es) |
YU (1) | YU40159B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043168A (en) * | 1990-04-26 | 1991-08-27 | Sidmak Laboratories, Inc. | Solid choline magnesium salicylate composition and method of preparing same |
US5217965A (en) * | 1991-06-17 | 1993-06-08 | Euroceltique, S.A. | Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
USD863685S1 (en) | 2017-11-27 | 2019-10-15 | Mary Kay Inc. | Cosmetic compact |
USD843660S1 (en) | 2017-11-27 | 2019-03-19 | Mary Kay Inc. | Cosmetic compact |
USD850006S1 (en) | 2017-11-27 | 2019-05-28 | Mary Kay Inc. | Cosmetic compact |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3347744A (en) * | 1963-10-25 | 1967-10-17 | Smith Kline French Lab | Magnesium hydroxide suspensions |
US3297529A (en) * | 1964-11-25 | 1967-01-10 | Sutton Lab Inc | Magnesium sulfate stabilized choline salicylate |
US3326760A (en) * | 1966-05-17 | 1967-06-20 | Synergistics Inc | Choline salicylate polygalacturonate therapy |
US3759980A (en) * | 1969-05-26 | 1973-09-18 | Stockton Chemicals Inc | Salicylates |
-
1976
- 1976-09-08 CA CA260,766A patent/CA1070299A/en not_active Expired
- 1976-11-25 IL IL50992A patent/IL50992A/xx unknown
- 1976-12-06 NZ NZ182810A patent/NZ182810A/xx unknown
- 1976-12-07 GR GR52348A patent/GR62110B/el unknown
- 1976-12-22 AR AR265966A patent/AR217249A1/es active
- 1976-12-23 SE SE7614538A patent/SE418799B/xx not_active IP Right Cessation
- 1976-12-30 ES ES454712A patent/ES454712A1/es not_active Expired
- 1976-12-30 FI FI763741A patent/FI56770C/fi not_active IP Right Cessation
-
1977
- 1977-01-10 CH CH25977A patent/CH635816A5/de not_active IP Right Cessation
- 1977-01-12 YU YU69/77A patent/YU40159B/xx unknown
- 1977-01-14 RO RO7789053A patent/RO71764A/ro unknown
- 1977-01-15 DE DE2760284A patent/DE2760284C2/de not_active Expired - Lifetime
- 1977-01-15 DE DE19772701553 patent/DE2701553A1/de active Granted
- 1977-01-18 AU AU21419/77A patent/AU511510B2/en not_active Expired
- 1977-01-19 NL NLAANVRAGE7700514,A patent/NL183821C/xx not_active IP Right Cessation
- 1977-01-19 EG EG36/77A patent/EG12511A/xx active
- 1977-01-20 FR FR7701571A patent/FR2338705A1/fr active Granted
- 1977-01-20 NO NO770172A patent/NO145295C/no unknown
- 1977-01-20 DK DK021677A patent/DK149804C/da not_active IP Right Cessation
- 1977-01-20 HU HU77MU577A patent/HU175973B/hu unknown
- 1977-01-21 MX MX775373U patent/MX5920E/es unknown
- 1977-01-21 GB GB2512/77A patent/GB1575977A/en not_active Expired
- 1977-01-21 DD DD7700197041A patent/DD128908A5/xx unknown
- 1977-01-21 JP JP52006319A patent/JPS6051449B2/ja not_active Expired
- 1977-01-21 GB GB9401/79A patent/GB1575978A/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR61307B (en) | Preparation process of pharmacologically active compounds | |
ZA763567B (en) | Pharmaceutically active complexes and pharmaceutical compositions containing them | |
GR60810B (en) | Preparation process of pharmaceutically active compounds | |
NZ182810A (en) | Solid stable choline salicylate compositions | |
JPS53109555A (en) | Preparation of modified keratin-containing material | |
JPS51146432A (en) | Process for preparation of benzanilide derivatives having therapeutic action to immunological disease | |
ES391536A1 (es) | Procedimiento para la obtencion de composiciones antibacte-riales. | |
JPS5279090A (en) | Preparation of powdered soy sauce | |
HU172133B (hu) | Sposob poluchenija kondensirovannykh proizvodnykh kinoksalina kak aktivnye immunregulirujuhhie agenty | |
ES423374A1 (es) | Un procedimiento para la preparacion de una composicion es-table para su aplicacion en el desengrasado a vapor de meta-les. | |
SE7614537L (sv) | Forfarande for framstellning av n?721-(2-tetra - hydrofuryl)-5-fluoruracil | |
JPS5225012A (en) | Stable aqueous solution disperting effective iodine in iodine mixture | |
JPS5248677A (en) | Preparation of pyrimidine derivatives | |
GB1093971A (en) | Improvements in novel mercury compound | |
ES458413A1 (es) | Mejoras introducidas en un procedimiento de preparacion de -una composicion de anoxicilina sodica. | |
JPS5219647A (en) | Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt | |
JPS52102412A (en) | Intermolecular compound of allantoin and basic amino acid | |
ES388436A2 (es) | Procedimiento para la preparacion de mezclas no aglutina- bles a base de tripolifosfato de sodio hexahidratadoy de ni-trilotriacetato de sodio mono o di-hidratado. | |
GB1042531A (en) | Therapeutic composition | |
JPS5231079A (en) | Preparation of uracil derivatives | |
JPS51113821A (en) | Preparation of pantethine | |
GB1099867A (en) | (phenylglycyl)-aminoacetonitriles | |
AU493271B2 (en) | Prostaglandin type compound in stable dosage form | |
JPS5268189A (en) | Preparation of pyrimidine-type nucleosides | |
JPS5236648A (en) | Preparation of 2-isopropyl-5,9,13- trimethyl-cyclotetradecanone |